Arakawa Chemical Industries,ltd.TSE: 4968

Consolidated Financial Results for the Six Months Ended September 30, 2024

· Issued by Arakawa Chemical Industries,ltd.

Consolidated Financial Results

for the Six Months Ended September 30, 2024

[Japanese GAAP]

November 5, 2024

Company name: ARAKAWA CHEMICAL INDUSTRIES, LTD.

Stock exchange listing: Tokyo Stock Exchange

Code number: 4968

URL: https://www.arakawachem.co.jp/en/

Representative: Nobuyuki Takagi, Representative Director and President

Contact: Toru Nobuhiro, Managing Director

Phone: +81-6-6209-8500

Scheduled date of filing semi-annual securities report: November 13, 2024

Scheduled date of commencing dividend payments: December 2, 2024

Availability of supplementary explanatory materials on financial results: Available

Schedule of financial results briefing session: Scheduled (for institutional investors/securities analysts)

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Six Months Ended September 30, 2024 (April 1, 2024 - September 30, 2024)

(1) Consolidated Operating Results

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable to

owners of parent

Six months ended

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

September 30, 2024

39,327

13.4

313

-

313

-

1,634

-

September 30, 2023

34,672

(16.9)

(1,827)

-

(1,451)

-

(753)

-

(Note) Comprehensive income: Six months ended September 30, 2024: ¥ 2,181 million [321.9%]

Six months ended September 30, 2023: ¥ 516 million [-%]

Basic earnings

Diluted earnings

per share

per share

Six months ended

Yen

Yen

September 30, 2024

82.41

-

September 30, 2023

(37.96)

-

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Millions of yen

Millions of yen

%

As of September 30, 2024

122,242

58,623

47.9

As of March 31, 2024

125,418

56,918

44.8

(Reference) Equity: As of September 30, 2024: ¥ 58,572 million As of March 31, 2024: ¥ 56,134 million

2. Dividends

Annual dividends

1st quarter-end

2nd quarter-end

3rd quarter-end

Year-end

Total

Yen

Yen

Yen

Yen

Yen

Fiscal year ended

-

24.00

-

24.00

48.00

March 31, 2024

Fiscal year ending

-

24.00

March 31, 2025

Fiscal year ending

March 31, 2025

-

24.00

48.00

(Forecast)

(Note) Revision to the forecast for dividends announced most recently: None

3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2025 (April 1, 2024 - March 31, 2025)

(% indicates changes from the previous corresponding period.)

Profit attributable

Basic earnings

Net sales

Operating profit

Ordinary profit

to owners of

per share

parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

Full year

82,000

13.5

1,500

-

1,200

-

2,100

-

105.85

(Note) Revision to the financial results forecast announced most recently: Yes

* Notes:

  1. Significant changes in the scope of consolidation during the period under review: None
    Newly included: - companies (Company name)
    Excluded: - companies (Company name)
  2. Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: None
  3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
    1. Changes in accounting policies due to the revision of accounting standards: None
    2. Changes in accounting policies other than 1) above: None
    3. Changes in accounting estimates: None
    4. Retrospective restatement: None
  4. Total number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury shares):

September 30, 2024:

20,652,400 shares

March 31, 2024:

20,652,400 shares

2) Total number of treasury shares at the end of the period:

September 30, 2024:

813,611 shares

March 31, 2024:

813,611 shares

3) Average number of shares during the period:

Six months ended September 30, 2024:

19,838,789 shares

Six months ended September 30, 2023:

19,838,909 shares

  • These semi-annual consolidated financial results are outside the scope of review by certified public accountants or an audit firm.
  • Explanation on the proper use of financial results forecast and other special notes

Forward-looking statements, including financial results forecasts, contained in this document are based on information currently available to the Company and certain assumptions deemed reasonable. Therefore, these statements do not constitute a guarantee that they will be realized. Actual results may differ materially from these statements due to various factors.

Semi-annual Consolidated Financial Statements and Principal Notes

(1) Semi-annual Consolidated Balance Sheets

(Millions of yen)

As of March 31, 2024

As of September 30, 2024

Assets

Current assets

Cash and deposits

Notes and accounts receivable - trade

Electronically recorded monetary claims - operating

Merchandise and finished goods

Work in process

Raw materials and supplies

Other

Allowance for doubtful accounts

Total current assets

Non-current assets

Property, plant and equipment

Buildings and structures, net Machinery, equipment and vehicles, net

Land

Construction in progress

Other, net

Total property, plant and equipment

Intangible assets

Investments and other assets

11,578

11,432

25,683

25,184

2,504

2,111

12,423

11,636

1,603

1,312

9,267

9,127

1,215

1,220

(116)

(125)

64,159

61,901

17,723

17,551

14,126

13,557

4,996

5,001

1,969

2,049

1,136

1,068

39,952

39,228

1,529

1,488

Investment securities

11,200

11,012

Retirement benefit asset

6,087

6,258

Deferred tax assets

286

325

Other

354

384

Allowance for doubtful accounts

(79)

(87)

Total investments and other assets

17,850

17,892

Total non-current assets

59,332

58,609

Deferred assets

Business commencement expenses

1,927

1,731

Total deferred assets

1,927

1,731

Total assets

125,418

122,242

(Millions of yen)

As of March 31, 2024

As of September 30, 2024

Liabilities

Current liabilities

Notes and accounts payable - trade Electronically recorded obligations - operating Short-term borrowings

Current portion of bonds payable

Income taxes payable

Accrued consumption taxes

Provision for bonuses

Provision for bonuses for directors (and other officers)

Provision for repairs

Provision for loss on business liquidation

Asset retirement obligations

Notes payable - facilities

Other

Total current liabilities

Non-current liabilities

9,478

8,103

1,403

1,132

18,512

17,405

5,000

5,000

434

644

100

211

1,190

1,181

-

10

732

469

110

78

-

174

297

151

6,146

5,496

43,406

40,060

Bonds payable

5,000

5,000

Long-term borrowings

13,875

12,450

Deferred tax liabilities

3,847

3,925

Retirement benefit liability

299

299

Asset retirement obligations

1,919

1,756

Other

151

125

Total non-current liabilities

25,093

23,557

Total liabilities

68,500

63,618

Net assets

Shareholders' equity

Share capital

Capital surplus

Retained earnings

Treasury shares

Total shareholders' equity

Accumulated other comprehensive income Valuation difference on available-for-sale securities

3,343

3,343

3,564

3,564

38,927

40,086

(1,211)

(1,211)

44,623

45,782

5,173

5,072

Foreign currency translation adjustment

3,530

5,070

Remeasurements of defined benefit plans

2,807

2,648

Total accumulated other comprehensive income

11,511

12,790

Non-controlling interests

783

51

Total net assets

56,918

58,623

Total liabilities and net assets

125,418

122,242

  1. Semi-annualConsolidated Statements of Income and Comprehensive Income Semi-annual Consolidated Statements of Income

(Millions of yen)

For the six months ended

For the six months ended

September 30, 2023

September 30, 2024

Net sales

34,672

39,327

Cost of sales

29,527

31,568

Gross profit

5,144

7,759

Selling, general and administrative expenses

6,972

7,445

Operating profit (loss)

(1,827)

313

Non-operating income

Interest income

46

55

Dividend income

115

114

Rental income from real estate

21

27

Foreign exchange gains

249

137

Other

153

91

Total non-operating income

586

427

Non-operating expenses

Interest expenses

145

189

Amortization of business commencement expenses

5

198

Other

59

39

Total non-operating expenses

210

427

Ordinary profit (loss)

(1,451)

313

Extraordinary income

Gain on sale of non-current assets

4

984

Gain on sale of investment securities

49

314

Total extraordinary income

54

1,299

Extraordinary losses

Loss on sale and retirement of non-current assets

121

45

Total extraordinary losses

121

45

Profit (loss) before income taxes

(1,519)

1,566

Income taxes - current

374

673

Income taxes - deferred

(243)

156

Total income taxes

131

830

Profit (loss)

(1,650)

736

Loss attributable to non-controlling interests

(897)

(898)

Profit (loss) attributable to owners of parent

(753)

1,634

Semi-annual Consolidated Statements of Comprehensive Income

(Millions of yen)

For the six months ended

For the six months ended

September 30, 2023

September 30, 2024

Profit (loss)

(1,650)

736

Other comprehensive income

Valuation difference on available-for-sale securities

1,265

(101)

Foreign currency translation adjustment

1,014

1,706

Remeasurements of defined benefit plans, net of tax

(112)

(160)

Total other comprehensive income

2,167

1,444

Comprehensive income

516

2,181

Comprehensive income attributable to

Comprehensive income attributable to owners of parent

1,253

2,914

Comprehensive income attributable to non-controlling

(736)

(732)

interests

(3) Semi-annual Consolidated Statements of Cash Flows

(Millions of yen)

For the six months ended

For the six months ended

September 30, 2023

September 30, 2024

Cash flows from operating activities

Profit (loss) before income taxes

Depreciation

Amortization of business commencement expenses

Increase (decrease) in allowance for doubtful accounts

Increase (decrease) in provision for bonuses

Increase (decrease) in provision for bonuses for directors (and other officers)

Increase (decrease) in retirement benefit liability Decrease (increase) in retirement benefit asset

Increase (decrease) in provision for loss on business liquidation

Loss (gain) on sale and retirement of non- current assets

Loss (gain) on sale of investment securities

Interest and dividend income

Interest expenses

Decrease (increase) in trade receivables

Decrease (increase) in inventories

Increase (decrease) in trade payables

Increase (decrease) in accrued consumption taxes

Other, net

Subtotal

Interest and dividends received

Interest paid

Income taxes refund (paid)

Net cash provided by (used in) operating activities

Cash flows from investing activities

(1,519)

1,566

2,779

2,709

5

198

(4)

2

5

(25)

-

10

15

(0)

(133)

(167)

(340)

(40)

116

(938)

(49)

(314)

(161)

(170)

145

189

(726)

1,615

510

1,715

(1,569)

(1,884)

330

307

(658)

(939)

(1,255)

3,833

160

176

(126)

(177)

(297)

(434)

(1,518)

3,398

Decrease (increase) in time deposits

Purchase of property, plant and equipment

Proceeds from sale of property, plant and equipment

38

393

(3,295)

(1,806)

5

769

Purchase of investment securities

Proceeds from sale of investment securities

Purchase of intangible assets

Payments for deferred assets

Decrease (increase) in investments and other assets

(19)

(19)

51

355

(29)

(58)

(28)

-

0

(8)

Other, net

(1)

(34)

Net cash provided by (used in) investing

(3,277)

(407)

activities

(Millions of yen)

For the six months ended

For the six months ended

September 30, 2023

September 30, 2024

Cash flows from financing activities

Net increase (decrease) in short-term

5,499

(1,126)

borrowings

Proceeds from long-term borrowings

391

-

Repayments of long-term borrowings

(695)

(1,652)

Dividends paid

(476)

(476)

Other, net

(41)

(8)

Net cash provided by (used in) financing

4,677

(3,264)

activities

Effect of exchange rate change on cash and cash

318

361

equivalents

Net increase (decrease) in cash and cash

200

88

equivalents

Cash and cash equivalents at beginning of period

9,286

9,164

Cash and cash equivalents at end of period

9,487

9,253

(4) Notes to Semi-annual Consolidated Financial Statements

(Segment information, etc.) [Segment information]

For the six months ended September 30, 2023 (from April 1, 2023 to September 30, 2023) 1. Information on net sales and income or loss by reportable segment

(Millions of yen)

Reportable segments

Functional

Paper

Adhesive &

Others

Chemicals &

Fine Chemicals

Total

Coating

Biomass

Total

(Note)

Environmental

& Electronics

Chemicals

Materials

Business

Net sales

Net sales to

6,937

9,883

12,393

5,419

34,633

38

34,672

external customers

Inter-segment sales

-

-

-

-

-

16

16

or transfers

Total

6,937

9,883

12,393

5,419

34,633

55

34,688

Segment income (loss)

109

330

(1,802)

(319)

(1,682)

16

(1,666)

Note: The "Others" category comprises business segments not included in reportable segments, such as non-life insurance business and real estate management.

2. Reconciliation of total income or loss of reportable segments with the amount reported in the semi-annual consolidated statements of income and main components of the difference (matters related to adjustments)

(Millions of yen)

Income

Amount

Total of reportable segments

(1,682)

Income in "Others" category

16

Variance from the allocation of corporate expenses (Note 1)

227

Corporate research and development expenses (Note 2)

(193)

Non-operating income and expenses (Note 3)

(195)

Operating loss in the semi-annual consolidated statements of income

(1,827)

Notes: 1. The variance from the allocation of corporate expenses primarily represents the difference in the estimated allocation of general and administrative expenses to reportable segments.

  1. Corporate research and development expenses represent new research and development costs not allocated to reportable segments, which are the source of medium- to long-term growth.
  2. Non-operatingincome and expenses primarily consist of items recorded as non-operating income and expenses in reportable segments.

3. Information on impairment losses on non-current assets or goodwill, etc., by reportable segment Not applicable